![]() ![]() ![]() ![]() |
Name: | acrB |
Gene(s): | acrB Genome Browser M3D Gene expression COLOMBOS |
Note(s): | Inactivation or inhibition of AcrAB-TolC activates the acrAB operon in response to cellular metabolism, such as enterobactin, cystein, and purine biosynthesis, and gluconeogenesis Ruiz C, Levy SB,2014 A feedback regulatory model has been proposed where the absence of a functional AcrAB-TolC pump leads to the accumulation of cellular metabolites, which usually leave cells via an AcrAB-TolC multidrug efflux pump. This accumulation results in the inactivation of AcrR and the induction of soxS and marA expression, ultimately triggering upregulation of acrAB expression to restore homeostasis Ruiz C, Levy SB,2014 Based on the bacteriostatic antibiotic-induced persister model, 37 and 9 genes were found to produce defects in rifampin- and tetracycline-induced persister formation, respectively. Only six mutants were found to overlap in both treatment-induced persister screens: recA, recC, ruvA, uvrD, fis, and acrB. Four of these mutants (recA, recC, ruvA, and uvrD) mapped to the DNA repair pathway, one mutant mapped to a global transcriptional regulator (fis), and one to a gene for an efflux protein (acrB) Cui P, Niu H, Shi W, Zhang S, Zhang W, Zhang Y,2018 Other genes that mapped to transporters, membrane biogenesis, LPS biosynthesis, flagellum biosynthesis, metabolism (folate and energy), and translation were more specific to rifampin-induced persisters Cui P, Niu H, Shi W, Zhang S, Zhang W, Zhang Y,2018 Sodium salicylate (NaSal), acetyl salicylic acid (ASA), acetaminophen (APAP), and ibuprofen contribute to antibiotic resistance by inducing the expression of both marA and acrB genes Verma T, Bhaskarla C, Sadhir I, Sreedharan S, Nandi D,2018 The induction by NaSal, ASA, and APAP is relatively higher and is partly dependent on marA, whereas ibuprofen, which induces lower antibiotic resistance, shows complete marA dependence. NaSal, ASA, APAP, and ibuprofen induce antibiotic resistance in an acrB-dependent manner Verma T, Bhaskarla C, Sadhir I, Sreedharan S, Nandi D,2018 A potential RNA G-quadruplex structure, formed by guanine-rich sequences located in the coding sequence region of the gene, was identified for acrB . This structure could regulate the expression of the gene, as observed for hemL gene expression Shao X, Zhang W, Umar MI, Wong HY, Seng Z, Xie Y, Zhang Y, Yang L, Kwok CK, Deng X,2020. |
Evidence: | [IC] Inferred by curator |
Promoter | |
Name: | acrBp |
+1: | 484685 |
Distance from start of the gene: | 282 |
Sequence: |
tcgtgcgcgcacgtctggaagaagggcttaatccaaacgctattttagtcccgcaacaggGcgtaacccgtacgccgcgtg |
Evidence: | [EXP-IDA-HPT-TRANSCR-INIT-M-RACE-MAP] |
Reference(s): | [1] Mendoza-Vargas A., et al., 2009 |
Name: | acrAB | ||||||||||
Gene(s): | acrB, acrA Genome Browser M3D Gene expression COLOMBOS | ||||||||||
Note(s): | The expression of the acrAB operon, which codes for an efflux pump for drugs, is induced under oxidative stress, although this induction does not occur immediately after the stress is generated Lu C,2003 On the other hand, it has been observed that decanoate induces the acrAB operon through the Rob transcription factor, but the specific mechanism remains to be investigated Rosenberg EY,2003 Dyszel et al. showed that the transcription of the acrAB and ftsQAZ operons were only increased by the overexpression of SdiA from a plasmid, while expression of these operons was not increased by chromosomal sdiA and the presence of N-(3-oxo-hexanoyl)-L-homoserine lactone (AHL) at either 30 C or 37 C Dyszel JL,2010 In addition, this operon is affected by tetracycline antibiotic pressure. As tetracycline concentration increases, the gene expression also increases Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M, Pagès JM, Amaral L,2007 In the same experiment, acrAB expression correlated with the gene expression of marA, which encodes an activator for the operon Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M, Pagès JM, Amaral L,2007 EnvR functions as a switch for the expression of acrAB and acrEF. It is not known which compound and/or condition induces the expression of EnvR Hirakawa H,2008 The DamX and Hns proteins appear to induce indirectly the expression of the acrA gene Ruiz C,2010 The acrAB operon is upregulated when E. coli is exposed to some biocides Merchel Piovesan Pereira B, Wang X, Tagkopoulos I,2020. Based on DNA microarray analysis, the mechanism of bacterial inactivation by carvacrol and citral was studied Chueca B, Pérez-Sáez E, Pagán R, García-Gonzalo D,2017. Treatment by both compounds caused membrane damage and activated metabolism through the production of nucleotides required for DNA and RNA synthesis and metabolic processes Chueca B, Pérez-Sáez E, Pagán R, García-Gonzalo D,2017. A total of 76 and 156 genes demonstrated significant transcriptional differences by carvacrol and citral, respectively. Genes upregulated by carvacrol treatment included the multidrug efflux pump genes acrA and mdtM, genes related to the phage shock response, pspA, pspB, pspC, pspD, pspF, and pspG, and genes whose products are important for biosynthesis of arginine (argC, argG, artJ) and purine nucleotides (purC, purM). Genes upregulated by citral treatment included purH, pyrB, and pyrI. On the other hand, mutations in several differentially expressed genes confirmed the roles of ygaV, yjbO, pspC, sdhA, yejG, and ygaV in mechanisms of inactivation by carvacrol and citral Chueca B, Pérez-Sáez E, Pagán R, García-Gonzalo D,2017. In a study where it was shown that the L-tryptophan eradicated persister cells, it was observed that the exogenous amino acid did not affect the expression of acrAB, whereas it did affect other genes Li Y, Liu B, Guo J, Cong H, He S, Zhou H, Zhu F, Wang Q, Zhang L,2019. Review about the regulation of the acrAB operon Weston N, Sharma P, Ricci V, Piddock LJV,2018. |
||||||||||
Evidence: | [EXP-IDA-TRANSCRIPT-LEN-DETERMINATION] Length of transcript experimentally determined [EXP-IEP] Inferred from expression pattern [EXP-IEP-COREGULATION] Inferred through co-regulation |
||||||||||
Reference(s): |
[2] Linde HJ., et al., 2000 [3] Ma D., et al., 1993 [4] Rand JD., et al., 2002 [5] Rosenberg EY., et al., 2003 |
||||||||||
Promoter | |||||||||||
Name: | acrAp | ||||||||||
+1: | 485698 | ||||||||||
Sigma Factor: | Sigma70 Sigmulon | ||||||||||
Distance from start of the gene: | 79 | ||||||||||
Sequence: |
gttcgtgaatttacaggcgttagatttacatacatttgtgaatgtatgtaccatagcacgAcgataatataaacgcagcaa -35 -10 +1 |
||||||||||
Note(s): | It has been demonstrated that the acrAp promoter is not affected by σS, the stress response sigma factor Rand JD,2002. | ||||||||||
Evidence: |
[COMP-AINF] [COMP-HINF] [COMP-HINF-POSITIONAL-IDENTIFICATION] [EXP-IDA-TRANSCRIPTION-INIT-MAPPING] |
||||||||||
Reference(s): |
[6] Eguchi Y., et al., 2003 [7] Huerta AM., et al., 2003 [8] Kobayashi A., et al., 2006 [9] Martin RG., et al., 1999 [4] Rand JD., et al., 2002 |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
proximal | AcrR | repressor | acrAp | 485709 | 485732 | -22.5 | gcgttagattTACATACATTTGTGAATGTATGTAccatagcacg | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [COMP-HINF-SIMILAR-TO-CONSENSUS], [EXP-DAP-SEQ], [EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | C | [12], [13], [14] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
proximal | EnvR | repressor | acrAp | 485709 | 485732 | -22.5 | gcgttagattTACATACATTTGTGAATGTATGTAccatagcacg | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [COMP-AINF-SIMILAR-TO-CONSENSUS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | W | [15] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
proximal | MarA | activator | acrAp | 485761 | 485780 | -72.5 | ttgcgcttctTGTTTGGTTTTTCGTGCCATatgttcgtga | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [COMP-AINF-SIMILAR-TO-CONSENSUS], [COMP-HINF-SIMILAR-TO-CONSENSUS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | W | [9], [11] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
proximal | MprA | repressor | acrAp | 485704 | 485724 | -16.0 | tttacatacaTTTGTGAATGTATGTACCATAgcacgacgat | nd | [COMP-AINF-SIMILAR-TO-CONSENSUS] | nd | [11] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
remote | PhoP-phosphorylated | repressor | acrAp | 485659 | 485675 | 32.0 | cgcagcaatgGGTTTATTAACTTTTGAccattgacca | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS] | W | [16] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
nd | Rob | activator | acrAp | nd | nd | nd | nd | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | W | [5] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
proximal | SoxS | activator | acrAp | 485761 | 485780 | -72.5 | ttgcgcttctTGTTTGGTTTTTCGTGCCATatgttcgtga | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [EXP-IEP-RNA-SEQ], [COMP-HINF], [COMP-HINF-SIMILAR-TO-CONSENSUS], [EXP-CHIP-EXO-MANUAL], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | C | [9], [10] |
RNA cis-regulatory element | ![]() |
---|
Regulation, transcriptional elongation | |
Attenuator type: | Transcriptional |
Strand: | reverse |
Structure type | Energy | LeftPos | RightPos | Sequence (RNA-strand) | |
---|---|---|---|---|---|
terminator | -7.7 | 485776 | 485800 | aggatgtgttGGCGCGTTTCTTGCGCTTCTTGTTtggtttttcg | |
anti-terminator | -9.9 | 485792 | 485828 | ctgtgagaaaAGACGTAGAGCCACATCGAGGATGTGTTGGCGCGTTtcttgcgctt |
Notes: "The provided "Sequence" is that of the RNA strand, i.e. U's are shown instead of T's and regulators on the reverse strand will appear as the reverse complement of the sequence delimited by LeftPos-RigtPos" |
Reference(s) |
![]() |
---|---|